Biogen Inc (BIIB)
224.93
+4.86
(+2.21%)
USD |
NASDAQ |
May 31, 16:00
224.94
+0.01
(+0.00%)
After-Hours: 20:00
Biogen SG&A Expense (TTM): 2.526B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 2.526B |
December 31, 2023 | 2.550B |
September 30, 2023 | 2.574B |
June 30, 2023 | 2.349B |
March 31, 2023 | 2.374B |
December 31, 2022 | 2.404B |
September 30, 2022 | 2.559B |
June 30, 2022 | 2.650B |
March 31, 2022 | 2.714B |
December 31, 2021 | 2.674B |
September 30, 2021 | 2.693B |
June 30, 2021 | 2.612B |
March 31, 2021 | 2.529B |
December 31, 2020 | 2.504B |
September 30, 2020 | 2.363B |
June 30, 2020 | 2.345B |
March 31, 2020 | 2.377B |
December 31, 2019 | 2.375B |
September 30, 2019 | 2.301B |
June 30, 2019 | 2.244B |
March 31, 2019 | 2.173B |
December 31, 2018 | 2.106B |
September 30, 2018 | 2.087B |
June 30, 2018 | 2.023B |
March 31, 2018 | 1.936B |
Date | Value |
---|---|
December 31, 2017 | 1.934B |
September 30, 2017 | 1.856B |
June 30, 2017 | 1.885B |
March 31, 2017 | 1.948B |
December 31, 2016 | 1.947B |
September 30, 2016 | 2.035B |
June 30, 2016 | 2.050B |
March 31, 2016 | 2.05B |
December 31, 2015 | 2.113B |
September 30, 2015 | 2.104B |
June 30, 2015 | 2.196B |
March 31, 2015 | 2.281B |
December 31, 2014 | 2.232B |
September 30, 2014 | 2.182B |
June 30, 2014 | 2.017B |
March 31, 2014 | 1.871B |
December 31, 2013 | 1.712B |
September 30, 2013 | 1.565B |
June 30, 2013 | 1.459B |
March 31, 2013 | 1.330B |
December 31, 2012 | 1.277B |
September 30, 2012 | 941.08M |
June 30, 2012 | 984.33M |
March 31, 2012 | 1.037B |
December 31, 2011 | 1.056B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
2.244B
Minimum
Jun 2019
2.714B
Maximum
Mar 2022
2.486B
Average
2.515B
Median
SG&A Expense (TTM) Benchmarks
Ionis Pharmaceuticals Inc | 239.74M |
Eli Lilly and Co | 6.912B |
Bristol-Myers Squibb Co | 8.377B |
Regeneron Pharmaceuticals Inc | 2.719B |
Sage Therapeutics Inc | 261.31M |